Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan
| Autor: | Fu Der Wang, Chen Hsiang Lee, Cheng Ting Hsu, Chien Wen Chen, Yao Shen Chen, Chien Hsien Huang, Chien Yu Cheng, Po-Yu Liu, Yu Lin Lee, Yhu Chering Huang, Huey-Kang Sytwu, Feng-Yee Chang, Chun Eng Liu, Shu Hsing Cheng, Cheng Len Sy, Chun Hsiang Chiu, Chia Chun Tseng, Jung Chung Lin, Yen Ling Chiu, Cheng-Pin Chen, Yuan Ti Lee, Yi-Chun Lin, Shiu Feng Huang, Yu-Ting Tseng |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Genomic data Pneumonia Viral Taiwan Article Betacoronavirus 03 medical and health sciences 0302 clinical medicine Pandemic medicine Humans Pandemics lcsh:QH301-705.5 Biological Specimen Banks Biobank lcsh:R5-920 SARS-CoV-2 COVID-19 Pneumonia General Medicine Hospitals COVID-19 Drug Treatment Important research 030104 developmental biology lcsh:Biology (General) 030220 oncology & carcinogenesis Family medicine Business Coronavirus Infections lcsh:Medicine (General) Consortium |
| Zdroj: | Biomedical Journal Biomedical Journal, Vol 43, Iss 4, Pp 314-317 (2020) |
| ISSN: | 2319-4170 |
| Popis: | By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients' blood samples for Taiwan researchers and industries in an emergent way. It was set up in less than 3 weeks and quickly opened for application. By August 5, 2020, this COVID-19 biobank has collected 165 blood samples of 110 patients from more than 10 hospitals across north, middle and south part of Taiwan, including both COVID-19 (+) and (-) pneumonia patients. This biobank can provide applicants with biosamples, such as serum, DNA and RNA, and also the clinical and genomic data, so as to accelerate the COVID-19 treatment and prevention research in Taiwan. This COID-19 biobank already received 15 applications. It has become the most important research resource for the COVID-19 pandemic in Taiwan, including new screening reagents, disease mechanism, the variable human responses and epidemic preventions. Since it is publicly available for both academic and industrial applicants. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|